Intelligent Disobedience in Healthcare: Navigating the Ethical Landscape and Upholding Justice
DOI:
https://doi.org/10.47611/jsrhs.v13i4.7601Keywords:
Intelligent Disobedience, Moral Courage, Ethics, Healthcare, Autonomy, Justice, Non-maleficence, Beneficence, Price Gouging, Deceptive Marketing, Unequal Access, ReformAbstract
In light of the pillars of healthcare ethics- beneficence, non-maleficence, autonomy, and justice- current practices in the healthcare field raise ethical questions regarding how to uphold these pillars. The concept of intelligent disobedience- refusing unlawful or harmful orders to uphold moral values- posits a viable solution in ensuring healthcare ethics are upheld for individuals in America. In the American healthcare system, the prevalence of price gouging, which refers to increasing medication prices to a level considered unfair to consumers, restricts individuals from obtaining needed medications for various conditions, demanding policy changes to ensure the pillars of beneficence and non-maleficence are upheld. Moreover, disparities in the healthcare field exacerbated by socioeconomic factors violate the pillar of justice in healthcare ethics, calling for telehealth services or mobile clinics to ensure adequate access to healthcare for all Americans. Lastly, deceptive marketing undermines the autonomy of individuals by failing to ensure informed consent, thus requiring stricter regulations to uphold the pillar of autonomy. By reforming the healthcare system to uphold the four pillars of healthcare ethics, Americans can strive for moral practices and set a standard for healthcare systems internationally.
Downloads
References or Bibliography
Atlas S. (2020). How to Reduce Prescription Drug Prices: First, Do No Harm. Missouri medicine, 117(1), 14–15.
Baird, H., Lopez, C., & Bhasin, C. (2015). The high costs of drugs (J. Sawayda, Ed.). Raymond J. Harbert College of Business. Retrieved March 6, 2024, from https://harbert.auburn.edu/binaries/documents/center-for-ethical-organizational-cultures/debate_issues/drug-costs.pdf
Betts, K. R., O'Donoghue, A. C., Johnson, M., Boudewyns, V., & Paquin, R. S. (2022). Detecting and Reporting Deceptive Prescription Drug Promotion: Differences Across Consumer and Physician Audiences and by Number and Type of Deceptive Claims and Tactics. Health communication, 37(13), 1609–1621. https://doi.org/10.1080/10410236.2021.1909264
Jones C. M. (2010). The moral problem of health disparities. American journal of public health, 100 Suppl 1(Suppl 1), S47–S51. https://doi.org/10.2105/AJPH.2009.171181
Keisler-Starkey, K., & Bunch, L. (2021, September 14). Health insurance coverage in the united states: 2020. United States Census Bureau. Retrieved March 10, 2024, from https://www.census.gov/library/publications/2021/demo/p60-274.html
Lawrence, J. (1975). Confrontation on the bridge [Image]. The Cleveland Museum of Art. https://www.clevelandart.org/art/1994.17
Lee, W. (2018). Willing the end means willing the means: An overlooked reading of kant. Ergo, an Open Access Journal of Philosophy, 5(20201214). https://doi.org/10.3998/ergo.12405314.0005.016
Maitland, I. (2002). Priceless Goods: How Should Life-Saving Drugs Be Priced? Business Ethics Quarterly, 12(4), 451–480. https://doi.org/10.2307/3857995
Mattingly, T. J., 2nd, & Hogue, M. D. (2020). Pharmacy's Call for Authorities to Aggressively Enforce Laws Addressing Price Gouging. Journal of managed care & specialty pharmacy, 26(8), 952–955. https://doi.org/10.18553/jmcp.2020.20166
McMaughan, D. J., Oloruntoba, O., & Smith, M. L. (2020). Socioeconomic Status and Access to Healthcare: Interrelated Drivers for Healthy Aging. Frontiers in public health, 8, 231. https://doi.org/10.3389/fpubh.2020.00231
Thomas, T., & Chaleff, I. (2017). Moral courage and intelligent disobedience. The InterAgency Journal, 8(1). https://thesimonscenter.org/wp-content/uploads/2017/03/IAJ-8-1-Winter2017-pg58-66.pdf
Tsou, A. Y., Graf, W. D., Russell, J. A., Epstein, L. G., & Ethics, Law, and Humanities Committee, a joint committee of the American Academy of Neurology (AAN), American Neurological Association (ANA), and Child Neurology Society (CNS) (2021). Ethical Perspectives on Costly Drugs and Health Care: AAN Position Statement. Neurology, 97(14), 685–692. https://doi.org/10.1212/WNL.0000000000012571
Villarán, A. (2017). Irrational Advertising and Moral Autonomy. Journal of Business Ethics, 144(3), 479–490. http://www.jstor.org/stable/45022184
Western Governors University. (2019, August 20). Healthcare ethics in modern medicine. https://www.wgu.edu/blog/healthcare-ethics-modern-medicine1908.html
Published
How to Cite
Issue
Section
Copyright (c) 2024 Arman Fard; Allison Cohen, Allison Cohen
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
